التفاصيل البيبلوغرافية
| العنوان: |
Building Infrastructure for Comparative Effectiveness Protocols (BICEP), 2002-2012 [Connecticut] |
| المؤلفون: |
Lynch, John |
| المساهمون: |
Inter-university Consortium for Political and Social Research distributor |
| المصدر: |
Inter-university Consortium for Political and Social Research ; practice management system (demographics, scheduling, charges, diagnoses, procedures); EHR (allergies, immunizations, medications, office measures, orders, notes, plans, problems, results, tasks, encounters, structured forms, scanned documents); laboratory system; provider credentialing system; United States Census data; and disease registries. |
| سنة النشر: |
2013 |
| مصطلحات موضوعية: |
2002--2012, info, demo |
| جغرافية الموضوع: |
Connecticut, United States |
| الوصف: |
CCPC's long term vision is to use pragmatic comparative effectiveness methods, linked to an extensive primary care practice data repository, to establish evidence about best practices for complex real world patients and deliver appropriate, real-time decision support at point of service for primary care practitioners (PCPs) in a way that will account for individualized management of conditions and choice of treatments in order to provide optimal care. The primary aim of BICEP was to advance analytical methods of observational Comparative Effectiveness Research (CER) to support evidentiary needs of primary care practitioners in answering important questions related to care of patient populations with Multiple Complex Conditions (MCCs). The secondary aim of BICEP was to conduct a pilot study to demonstrate the feasibility and value of using the analytic methods for conducting CER among complex patients. BICEP sought to answer the following clinical research questions: In adults with Type 2 Diabetes Mellitus (T2DM) coupled with additional chronic diseases, What is the comparative effectiveness of T2DM medications in achieving glycemic control? What is the comparative effectiveness of T2DM medications on intermediate outcomes, adverse events, side effects, tolerability? Does the effectiveness and safety of the diabetic treatment options differ across subgroups of patients based on patient demographic characteristics, complex co-morbidities, or the use of other concurrent therapies? |
| نوع الوثيقة: |
other/unknown material |
| اللغة: |
Ukrainian |
| العلاقة: |
34447; http://doi.org/10.3886/ICPSR34447.v1Test |
| DOI: |
10.3886/ICPSR34447.v1 |
| الإتاحة: |
https://doi.org/10.3886/ICPSR34447.v1Test |
| حقوق: |
undefined |
| رقم الانضمام: |
edsbas.52E68506 |
| قاعدة البيانات: |
BASE |
